Skip to menu Skip to content Skip to footer

2010

Journal Article

Enoxaparin in Primary and Facilitated Percutaneous Coronary Intervention A Formal Prospective Nonrandomized Substudy of the FINESSE Trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)

Montalescot, Gilles, Ellis, Stephen G., de Belder, Mark A., Janssens, Luc, Katz, Olivier, Pluta, Wladyslaw, Ecollan, Patrick, Tendera, Michal, van Boven, Ad J., Widimsky, Petr, Andersen, Henning R., Betriu, Amadeo, Armstrong, Paul, Brodie, Bruce R., Herrmann, Howard C., Neumann, Franz-Josef, Effron, Mark B., Lu, Jiandong, Barnathan, Elliot S. and Topol, Eric J. (2010). Enoxaparin in Primary and Facilitated Percutaneous Coronary Intervention A Formal Prospective Nonrandomized Substudy of the FINESSE Trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). Jacc-Cardiovascular Interventions, 3 (2), 203-212. doi: 10.1016/j.jcin.2009.11.012

Enoxaparin in Primary and Facilitated Percutaneous Coronary Intervention A Formal Prospective Nonrandomized Substudy of the FINESSE Trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)

2009

Conference Publication

Comparison of Prasugel With Clopidogrel on Platelet Function in Coronary Artery Disease Patients With Type 2 Diabetes Mellitus - Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

Angiolillo, Dominick J., Badimon, Juan, Saucedo, Jorge F., Frelinger, Andrew L., Michelson, Alan D., Jakubowski, Joseph A., Zhu, Baojin, Ojeh, Clement K., Baker, Brian and Effron, Mark B. (2009). Comparison of Prasugel With Clopidogrel on Platelet Function in Coronary Artery Disease Patients With Type 2 Diabetes Mellitus - Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3). 82nd Scientific Session of the American-Heart-Association, Orlando Fl, Nov 14-18, 2009. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Comparison of Prasugel With Clopidogrel on Platelet Function in Coronary Artery Disease Patients With Type 2 Diabetes Mellitus - Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

2009

Conference Publication

Decrease in Poor Responders on Switching From Clopidogrel to Prasugrel: Results From the SWitching Anti Platelet (SWAP) Study

Saucedo, Jorge F., Angiolillo, Dominick J., DeRaad, Roger, Frelinger, Andrew L., Gurbel, Paul A., Costigan, Timothy M., Jakubowski, Joseph A., Ojeh, Clement K. and Effron, Mark B. (2009). Decrease in Poor Responders on Switching From Clopidogrel to Prasugrel: Results From the SWitching Anti Platelet (SWAP) Study. 82nd Scientific Session of the American-Heart-Association, Orlando Fl, Nov 14-18, 2009. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Decrease in Poor Responders on Switching From Clopidogrel to Prasugrel: Results From the SWitching Anti Platelet (SWAP) Study

2009

Journal Article

Response to Letter Regarding Article "Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in the Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors"

Collins, Peter, Mosca, Lori, Geiger, Mary Jane, Amewou-Atisso, Messan G., Effron, Mark B., Dowsett, Sherie, Grady, Deborah, Kornitzer, Marcel, Barrett-Connor, Elizabeth and Wenger, Nanette K. (2009). Response to Letter Regarding Article "Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in the Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors". Circulation, 120 (17), E148-E148. doi: 10.1161/CIRCULATIONAHA.109.876920

Response to Letter Regarding Article "Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in the Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors"

2009

Journal Article

1-Year Survival in a Randomized Trial of Facilitated Reperfusion Results From the FINESSE (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events) Trial

Ellis, Stephen G., Tendera, Michal, de Belder, Mark A., van Boven, Ad J., Widimsky, Petr, Andersen, Henning R., Betriu, Amadeo, Savonitto, Stefano, Adamus, Jerzy, Peruga, Jan Z., Hamankiewicz, Maciej, Pluta, Waladyslaw, Oldroyd, Keith, Ecollan, Patrick, Janssens, Luc, Armstrong, Paul, Brodie, Bruce R., Herrmann, Howard C., Montalescot, Gilles, Neumann, Franz-Josef, Effron, Mark B., Bamathan, Elliot S. and Topol, Eric J. (2009). 1-Year Survival in a Randomized Trial of Facilitated Reperfusion Results From the FINESSE (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events) Trial. Jacc-Cardiovascular Interventions, 2 (10), 909-916. doi: 10.1016/j.jcin.2009.07.009

1-Year Survival in a Randomized Trial of Facilitated Reperfusion Results From the FINESSE (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events) Trial

2009

Conference Publication

PRASUGREL AND CLOPIDOGREL PERSISTENCE AND DISCONTINUATION AMONG LOWER BLEEDING RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES

Zhu, B., McCollam, P. L., Bae, J. P., Ramaswamy, K., Johnston, J. A. and Effron, M. B. (2009). PRASUGREL AND CLOPIDOGREL PERSISTENCE AND DISCONTINUATION AMONG LOWER BLEEDING RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES. MALDEN: WILEY-BLACKWELL PUBLISHING, INC. doi: 10.1016/S1098-3015(10)74562-9

PRASUGREL AND CLOPIDOGREL PERSISTENCE AND DISCONTINUATION AMONG LOWER BLEEDING RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES

2009

Journal Article

Benefit of Facilitated Percutaneous Coronary Intervention in High-Risk ST-Segment Elevation Myocardial Infarction Patients Presenting to Nonpercutaneous Coronary Intervention Hospitals

Herrmann, Howard C., Lu, Jiandong, Brodie, Bruce R., Armstrong, Paul W., Montalescot, Gilles, Betriu, Amadeo, Neuman, Franz-Joseph, Effron, Mark B., Barnathan, Elliot S., Topol, Eric J. and Ellis, Stephen G. (2009). Benefit of Facilitated Percutaneous Coronary Intervention in High-Risk ST-Segment Elevation Myocardial Infarction Patients Presenting to Nonpercutaneous Coronary Intervention Hospitals. Jacc-Cardiovascular Interventions, 2 (10), 917-924. doi: 10.1016/j.jcin.2009.06.018

Benefit of Facilitated Percutaneous Coronary Intervention in High-Risk ST-Segment Elevation Myocardial Infarction Patients Presenting to Nonpercutaneous Coronary Intervention Hospitals

2009

Conference Publication

REDUCTION IN REHOSPITALIZATIONS AND ASSOCIATED COSTS WITHIN 30 DAYS AFTER DISCHARGE FROM HOSPITALIZATION FOR ACUTE CORONARY SYNDROMES AND PLANNED PCI WITH PRASUGREL VS. CLOPIDOGREL: RESULTS FROM THE TRITON-TIMI 38 TRIAL FOR PATIENTS WITH NO HISTORY OF STROKE OR TIA

Mahoney, E. M., Wang, K., Bae, J. P., Zhu, B., Marciniak, M. D., Effron, M. B. and Cohen, D. J. (2009). REDUCTION IN REHOSPITALIZATIONS AND ASSOCIATED COSTS WITHIN 30 DAYS AFTER DISCHARGE FROM HOSPITALIZATION FOR ACUTE CORONARY SYNDROMES AND PLANNED PCI WITH PRASUGREL VS. CLOPIDOGREL: RESULTS FROM THE TRITON-TIMI 38 TRIAL FOR PATIENTS WITH NO HISTORY OF STROKE OR TIA. MALDEN: WILEY-BLACKWELL PUBLISHING, INC. doi: 10.1016/S1098-3015(10)74653-2

REDUCTION IN REHOSPITALIZATIONS AND ASSOCIATED COSTS WITHIN 30 DAYS AFTER DISCHARGE FROM HOSPITALIZATION FOR ACUTE CORONARY SYNDROMES AND PLANNED PCI WITH PRASUGREL VS. CLOPIDOGREL: RESULTS FROM THE TRITON-TIMI 38 TRIAL FOR PATIENTS WITH NO HISTORY OF STROKE OR TIA

2009

Journal Article

Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial Results of Subgroup Analyses by Age and Other Factors

Collins, Peter, Mosca, Lori, Geiger, Mary Jane, Grady, Deborah, Kornitzer, Marcel, Amewou-Atisso, Messan G., Effron, Mark B., Dowsett, Sherie A., Barrett-Connor, Elizabeth and Wenger, Nanette K. (2009). Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial Results of Subgroup Analyses by Age and Other Factors. Circulation, 119 (7), 922-930. doi: 10.1161/CIRCULATIONAHA.108.817577

Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial Results of Subgroup Analyses by Age and Other Factors

2008

Journal Article

Treating Patients With 'Wake-Up' Stroke The Experience of the AbESTT-II Trial

Adams, Harold P., Leira, Enrique C., Torner, James C., Barnathan, Elliot, Padgett, Lakshmi, Effron, Mark B. and Hacke, Werner (2008). Treating Patients With 'Wake-Up' Stroke The Experience of the AbESTT-II Trial. Stroke, 39 (12), 3277-3282. doi: 10.1161/STROKEAHA.107.508853

Treating Patients With 'Wake-Up' Stroke The Experience of the AbESTT-II Trial

2008

Conference Publication

COMPARISON OF PERSISTENCE AND ADHERENCE BETWEEN PRASUGREL AND CLOPIDOGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND PERCUTANEOUS CORONARY INTERVENTIONS

Bae, J. P., Zhu, B., McCollam, P. L., Ramaswamy, K., Johnston, J. A., Cohen, D. J. and Effron, M. B. (2008). COMPARISON OF PERSISTENCE AND ADHERENCE BETWEEN PRASUGREL AND CLOPIDOGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND PERCUTANEOUS CORONARY INTERVENTIONS. MALDEN: WILEY-BLACKWELL PUBLISHING, INC. doi: 10.1016/S1098-3015(10)66384-X

COMPARISON OF PERSISTENCE AND ADHERENCE BETWEEN PRASUGREL AND CLOPIDOGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND PERCUTANEOUS CORONARY INTERVENTIONS

2008

Conference Publication

Benefit of Facilitated PCI in High Risk ST Elevation MI Patients Presenting to Non-PCI Hospitals

Herrmann, Howard C., Liu, Jiandong, Brodie, Bruce R., Armstrong, Paul W., Montalescot, Gilles, Betriu, Amadeo, Neumann, Franz-Josef, Effron, Mark B., Barnathan, Elliot S., Topol, Eric. J. and Ellis, Stephen G. (2008). Benefit of Facilitated PCI in High Risk ST Elevation MI Patients Presenting to Non-PCI Hospitals. 20th Annual Transcatheter Cardiovascular Therapeutics Conference, Washington Ca, Oct 12-17, 2008. BRIDGEWATER: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC.

Benefit of Facilitated PCI in High Risk ST Elevation MI Patients Presenting to Non-PCI Hospitals

2008

Journal Article

Antibiotic overuse: The influence of social norms

Buchman, Timothy G., Dushoff, Jonathan, Effron, Mark B., Ehrlich, Paul R., Fitzpatrick, Susan, Laxminarayan, Ramanan, Levin, Bruce, Levin, Simon A., Lipsitch, Marc, Malani, Anup, Nemeroff, Carol, Otto, Sarah P., Patel, Vimla L. and Solomkin, Joseph S. (2008). Antibiotic overuse: The influence of social norms. Journal of the American College of Surgeons, 207 (2), 265-275. doi: 10.1016/j.jamcollsurg.2008.02.035

Antibiotic overuse: The influence of social norms

2008

Journal Article

Facilitated PCI in patients with ST-elevation myocardial infarction

Ellis, Stephen G., Tendera, Michal, de Belder, Mark A., van Boven, Ad J., Widimsky, Petr, Janssens, Luc, Andersen, H. R., Betriu, Amadeo, Savonitto, Stefano, Adamus, Jerzy, Peruga, Jan Z., Kosmider, Maciej, Katz, Olivier, Neunteufl, Thomas, Jorgova, Julia, Dorobantu, Maria, Grinfeld, Liliana, Armstrong, Paul, Brodie, Bruce R., Herrmann, Howard C., Montalescot, Gilles, Neumann, Franz-Josef, Effron, Mark B., Barnathan, Elliot S. and Topol, Eric J. (2008). Facilitated PCI in patients with ST-elevation myocardial infarction. New England Journal of Medicine, 358 (21), 2205-2217. doi: 10.1056/NEJMoa0706816

Facilitated PCI in patients with ST-elevation myocardial infarction

2008

Conference Publication

One year follow up results of the FINESSE trial of facilitated PCI

Ellis, Stephen G., Tendera, Michael, De Belder, Mark A., van Boven, Ad J., Widimsky, Petr, Janssens, Luc, Andersen, H. R., Betriu, Amadeo, Savonitto, Stefano, Adamus, Jerzy, Peruga, Jan Z., Kosmider, Maciej, Katz, Olivier, Neunteufl, Thomas, Jorgova, Julia, Dorobantu, Maria, Grinfeld, Liliana, Armstrong, Paul, Brodie, Bruce, Herrmann, Howard C., Montalescot, Gilles, Neumann, Franz-Josef, Effron, Mark B., Barnathan, Elliot S. and Topol, Eric J. (2008). One year follow up results of the FINESSE trial of facilitated PCI. 57th Annual Scientific Session of the American-College-of-Cardiology, Chicago Il, Mar 29-Apr 01, 2008. NEW YORK: ELSEVIER SCIENCE INC.

One year follow up results of the FINESSE trial of facilitated PCI

2008

Journal Article

Emergency administration of abciximab for treatment of patients with acute ischemic stroke: Results of an international phase III trial - Abciximab in emergency treatment of stroke trial (AbESTT-II)

Adams, Harold P., Effron, Mark B., Torner, James, Davalos, Antoni, Frayne, Judith, Teal, Philip, Leclerc, Jacques, Oemar, Barry, Padgett, Lakshmi, Barnathan, Elliot S. and Hacke, Werner (2008). Emergency administration of abciximab for treatment of patients with acute ischemic stroke: Results of an international phase III trial - Abciximab in emergency treatment of stroke trial (AbESTT-II). Stroke, 39 (1), 87-99. doi: 10.1161/STROKEAHA.106.476648

Emergency administration of abciximab for treatment of patients with acute ischemic stroke: Results of an international phase III trial - Abciximab in emergency treatment of stroke trial (AbESTT-II)

2007

Conference Publication

The FINESSE (Facilitated intervention with enhanced reperfusion speed to stop events) trial: Results of the formal low molecular weight heparin substudy

Montalescot, Gilles, Ellis, Stephen G., de Belder, Mark A., Janssens, Luc, Andersen, H. R., Pluta, Wladyslaw, Katz, Olivier, Ecollan, Patrick, Sorensen, Vigholt E., Dawkins, Keith D., Miarka, Jacek, de Belder, Adam, Lederballe, Ole, Adgey, Jennifer, Effron, Mark B. and Barnathan, Elliot S. (2007). The FINESSE (Facilitated intervention with enhanced reperfusion speed to stop events) trial: Results of the formal low molecular weight heparin substudy. 19th Annual Transcatheter Cardiovascular Therapeutics Symposium, Washington Dc, Oct 20-25, 2007. BRIDGEWATER: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC.

The FINESSE (Facilitated intervention with enhanced reperfusion speed to stop events) trial: Results of the formal low molecular weight heparin substudy

2007

Conference Publication

The FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial: Results of the formal low molecular weight heparin substudy

Montalescot, Gilles, De Belder, Marka A., Janssens, Luc, Andersen, H. R., Pluta, Wladyslaw, Katz, Olivier, Ecollan, Patrick, Sorensen, Vigholt E., Dawkins, Keith D., Miarka, Jacek, De Belder, Adam, Lederballe, Ole, Adgey, Jennifer, Effron, Mark B., Barnathan, Elliot S. and Ellis, Stephen G. (2007). The FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial: Results of the formal low molecular weight heparin substudy. 19th Annual Transcatheter Cardiovascular Therapeutics Symposium, Washington Dc, Oct 20-25, 2007. BRIDGEWATER: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC.

The FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial: Results of the formal low molecular weight heparin substudy

2005

Conference Publication

The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease

Patterson, D, Kloner, R, Effron, M, Emmick, J, Bedding, A, Warner, M, Mitchell, M, Braat, S and MacDonald, T (2005). The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease. Meeting of the International-Society-for-Sexual-and-Impotence-Research, Montreal Canada, Sep, 2002. OXFORD: BLACKWELL PUBLISHING. doi: 10.1111/j.1365-2125.2005.02479.x

The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease

2005

Journal Article

Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction

Nikolsky, E, Sadeghi, HM, Effron, MB, Mehran, R, Lansky, AJ, Na, YB, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Stuckey, TD, Turco, M, Carroll, JD, Grines, CL and Stone, GW (2005). Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. American Journal of Cardiology, 96 (4), 474-481. doi: 10.1016/j.amjcard.2005.04.005

Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction